D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 80 Citations 20,538 259 World Ranking 9577 National Ranking 5170

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Schizophrenia

Jan Volavka mostly deals with Psychiatry, Schizophrenia, Internal medicine, Clinical psychology and Psychosis. The study incorporates disciplines such as Cohort study and Psychopathy in addition to Psychiatry. His Schizophrenia research integrates issues from Anesthesia and Pharmacotherapy.

His Internal medicine study incorporates themes from Extrapyramidal symptoms and Endocrinology. His work on Psychopathology as part of general Clinical psychology research is frequently linked to Victimology, bridging the gap between disciplines. His study in Psychosis is interdisciplinary in nature, drawing from both Allele and Catechol-O-methyl transferase.

His most cited work include:

  • The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. (666 citations)
  • The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. (666 citations)
  • Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder (459 citations)

What are the main themes of his work throughout his whole career to date?

Psychiatry, Schizophrenia, Clinical psychology, Internal medicine and Antipsychotic are his primary areas of study. The Aggression and Olanzapine research Jan Volavka does as part of his general Psychiatry study is frequently linked to other disciplines of science, such as Injury prevention, Suicide prevention and Human factors and ergonomics, therefore creating a link between diverse domains of science. In his work, Dopamine antagonist is strongly intertwined with Risperidone, which is a subfield of Olanzapine.

His work carried out in the field of Schizophrenia brings together such families of science as Haloperidol and Psychosis. Psychosis is closely attributed to Catechol-O-methyl transferase in his work. His Clinical psychology research is multidisciplinary, relying on both Personality disorders and Psychopathy.

He most often published in these fields:

  • Psychiatry (67.32%)
  • Schizophrenia (44.44%)
  • Clinical psychology (26.14%)

What were the highlights of his more recent work (between 2007-2021)?

  • Psychiatry (67.32%)
  • Schizophrenia (44.44%)
  • Clinical psychology (26.14%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Psychiatry, Schizophrenia, Clinical psychology, Aggression and Antipsychotic. His work in the fields of Olanzapine and Mental illness overlaps with other areas such as Injury prevention. His biological study focuses on Clozapine.

His Clozapine research includes elements of Haloperidol and Akathisia. His work in the fields of Clinical psychology, such as Psychopathology and Conduct disorder, overlaps with other areas such as Antisocial personality disorder. The concepts of his Internal medicine study are interwoven with issues in Schizoaffective disorder, Anesthesia and Extrapyramidal symptoms.

Between 2007 and 2021, his most popular works were:

  • Mental disorder and violence: is there a relationship beyond substance use? (213 citations)
  • Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia (149 citations)
  • Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. (129 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Psychiatry
  • Schizophrenia

His primary scientific interests are in Psychiatry, Schizophrenia, Olanzapine, Internal medicine and Meta-analysis. His research on Psychiatry frequently links to adjacent areas such as Odds ratio. His work deals with themes such as Personality disorders, Aggression and Clinical psychology, which intersect with Schizophrenia.

His biological study spans a wide range of topics, including Clozapine and Psychopathy. His Clozapine research is multidisciplinary, incorporating elements of Haloperidol, Psychopharmacology, Psychosis and Personality. His study in the field of Randomized controlled trial, Discontinuation and Adjunctive treatment is also linked to topics like Placebo-controlled study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.

Robert M Bilder;Jan Volavka;Jan Volavka;Herbert M Lachman;Anthony A Grace.
Neuropsychopharmacology (2004)

858 Citations

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

Robert M. Bilder;Robert S. Goldman;Jan Volavka;Pal Czobor.
American Journal of Psychiatry (2002)

715 Citations

Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical Antipsychotics

Jean Pierre Lindenmayer;Pal Czobor;Jan Volavka;Leslie Citrome.
American Journal of Psychiatry (2003)

680 Citations

Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder

Jan Volavka;Pal Czobor;Brian Sheitman;Jean Pierre Lindenmayer.
American Journal of Psychiatry (2002)

544 Citations

Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study.

Jari Tiihonen;Kristian Wahlbeck;Jouko Lönnqvist;Timo Klaukka.
BMJ (2006)

441 Citations

Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia

Robert M. Bilder;Jan Volavka;Pál Czobor;Anil K. Malhotra.
Biological Psychiatry (2002)

435 Citations

Neurobiology of violence

Jan Volavka.
(1995)

388 Citations

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing.

Karl Verebey;Jan Volavka;Salvatore J. Mule;R. B. Resnick.
Clinical Pharmacology & Therapeutics (1976)

368 Citations

Mental disorder and violence: is there a relationship beyond substance use?

Richard Van Dorn;Jan Volavka;Norman Johnson.
Social Psychiatry and Psychiatric Epidemiology (2012)

347 Citations

Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder.

Herbert M. Lachman;Karen A. Nolan;Pavel Mohr;Takuya Saito.
American Journal of Psychiatry (1998)

322 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jan Volavka

Leslie Citrome

Leslie Citrome

New York Medical College

Publications: 112

Herbert Y. Meltzer

Herbert Y. Meltzer

Northwestern University

Publications: 72

Marc A. Schuckit

Marc A. Schuckit

University of California, San Diego

Publications: 64

Sheilagh Hodgins

Sheilagh Hodgins

University of Montreal

Publications: 58

Jari Tiihonen

Jari Tiihonen

Karolinska Institute

Publications: 51

Jeffrey A. Lieberman

Jeffrey A. Lieberman

Columbia University

Publications: 51

James L. Kennedy

James L. Kennedy

Centre for Addiction and Mental Health

Publications: 46

John M. Kane

John M. Kane

Feinstein Institute for Medical Research

Publications: 41

Philip D. Harvey

Philip D. Harvey

University of Miami

Publications: 40

David Goldman

David Goldman

National Institutes of Health

Publications: 38

Eduard Vieta

Eduard Vieta

University of Barcelona

Publications: 36

Daniel R. Weinberger

Daniel R. Weinberger

Johns Hopkins University

Publications: 36

Hans-Jürgen Möller

Hans-Jürgen Möller

Ludwig-Maximilians-Universität München

Publications: 35

Gary Remington

Gary Remington

Centre for Addiction and Mental Health

Publications: 34

Christoph U. Correll

Christoph U. Correll

Charité - University Medicine Berlin

Publications: 34

Stefan Leucht

Stefan Leucht

Technical University of Munich

Publications: 30

Trending Scientists

Anatole Lécuyer

Anatole Lécuyer

French Institute for Research in Computer Science and Automation - INRIA

Qun Liu

Qun Liu

Huawei Technologies (China)

Alexander G. Gounares

Alexander G. Gounares

Microsoft (United States)

Julian R.H. Ross

Julian R.H. Ross

University of Limerick

Michael Bühl

Michael Bühl

University of St Andrews

Seyed E. Hasnain

Seyed E. Hasnain

Indian Institute of Technology Delhi

Norman E. Davey

Norman E. Davey

Institute of Cancer Research

Nancy Hogg

Nancy Hogg

Cancer Research UK London Research Institute

Judith P. Johnson

Judith P. Johnson

Ludwig-Maximilians-Universität München

Hans Puxbaum

Hans Puxbaum

TU Wien

George L. Siscoe

George L. Siscoe

University of California, Los Angeles

Murray Sidman

Murray Sidman

Northeastern University

Alpa V. Patel

Alpa V. Patel

American Cancer Society

Graham Dunn

Graham Dunn

University of Manchester

Christian C. Abnet

Christian C. Abnet

National Institutes of Health

Drake Deming

Drake Deming

University of Maryland, College Park

Something went wrong. Please try again later.